Wang, J; Ethridge, LE; Mosconi, MW; White, SP; Binder, DK; Pedapati, EV; Erickson, CA; Byerly, MJ; Sweeney, JA.
A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome.
Journal of Neurodevelopmental Disorders.
2017;
9.
Erickson, CA; Davenport, MH; Schaefer, TL; Wink, LK; Pedapati, EV; Sweeney, JA; Fitzpatrick, SE; Brown, WT; Budimirovic, D; Hagerman, RJ; et al.
Fragile X targeted pharmacotherapy: lessons learned and future directions.
Journal of Neurodevelopmental Disorders.
2017;
9.
Ethridge, LE; White, SP; Mosconi, MW; Wang, J; Pedapati, EV; Erickson, CA; Byerly, MJ; Sweeney, JA.
Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome.
Molecular Autism.
2017;
8.
Wink, LK; Minshawi, NF; Shaffer, RC; Plawecki, MH; Posey, DJ; Horn, PS; Adams, R; Pedapati, EV; Schaefer, TL; McDougle, CJ; et al.
d-Cycloserine enhances durability of social skills training in autism spectrum disorder.
Molecular Autism.
2017;
8.
Muhle, RA; Reed, HE; Vo, LC; Mehta, S; McGuire, K; Veenstra-VanderWeele, J; Pedapati, E.
Clinical Diagnostic Genetic Testing for Individuals With Developmental Disorders.
Journal of the American Academy of Child and Adolescent Psychiatry.
2017;
56:910-913.
Scher, MS; Breningstall, G; Gilbert, DL; Jordan, L; Khakoo, Y; LePichon, J.
Editorial: The 2016 Pediatric Neurology Trainee Publication Award.
Pediatric Neurology.
2017;
75:3-3.
Hong, MP; Guilfoyle, JL; Mooney, LN; Wink, LK; Pedapati, EV; Shaffer, RC; Sweeney, JA; Erickson, CA.
Eye gaze and pupillary response in Angelman syndrome.
Research in Developmental Disabilities.
2017;
68:88-94.
McClellan, L; Dominick, KC; Pedapati, EV; Wink, LK; Erickson, CA.
Lurasidone for the treatment of irritability and anger in autism spectrum disorders.
Expert Opinion on Investigational Drugs.
2017;
26:985-989.
Harkins, CM; Dominick, KC; Wink, LK; Pedapati, EV; Shaffer, RC; Fitzpatrick, SE; Davenport, MH; Sweeney, JA; Erickson, CA.
Challenges in Conducting Clinical Trials for Pharmacotherapies in Fragile X Syndrome: Lessons Learned.
Pharmaceutical Medicine.
2017;
31:235-244.
Barfell, KS F; Snyder, RR; Isaacs-Cloes, KM; Garris, JF; Roeckner, AR; Horn, PS; Guthrie, MD; Wu, SW; Gilbert, DL.
Parent and Patient Perceptions of Functional Impairment Due to Tourette Syndrome: Development of a Shortened Version of the Child Tourette Syndrome Impairment Scale.
Journal of Child Neurology.
2017;
32:725-730.
Wink, LK; Adams, R; Pedapati, EV; Dominick, KC; Fox, E; Buck, C; Erickson, CA.
Brief Report: Metformin for Antipsychotic-Induced Weight Gain in Youth with Autism Spectrum Disorder.
Journal of Autism and Developmental Disorders.
2017;
47:2290-2294.
Albert, DV F; Gilbert, DL.
Child Neurology Training for Pediatricians.
Pediatric Neurology.
2017;
71:4-7.
Gilbert, DL.
Drug-Induced Movement Disorders in Children.
Swaiman's Pediatric Neurology: Principles and Practice: Sixth Edition.
:
Elsevier;
Elsevier;
2017.
Augustine, EF; Gilbert, DL.
Clinical pearls and scientific advancement Reconciling tradition with new knowledge.
Neurology.
2017;
88:1786-1787.
Willsey, AJ; Fernandez, TV; Yu, D; King, RA; Dietrich, A; Xing, J; Sanders, SJ; Mandell, JD; Huang, AY; Richer, P; et al.
De Novo Coding Variants Are Strongly Associated with Tourette Disorder.
Neuron.
2017;
94:486-499.e9.
Wang, J; Ethridge, LE; Mosconi, MW; White, SP; Binder, DK; Pedapati, EV; Erickson, CA; Byerly, MJ; Sweeney, JA.
A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome.
Journal of Neurodevelopmental Disorders.
2017;
9.
Arya, R; Spaeth, C; Gilbert, DL; Leach, JL; Holland, KD.
GNAO1-associated epileptic encephalopathy and movement disorders: c.607G> A variant represents a probable mutation hotspot with a distinct phenotype.
Epileptic Disorders: international epilepsy journal with videotape.
2017;
19:67-75.
Cloes, KI; Barfell, KS F; Horn, PS; Wu, SW; Jacobson, SE; Hart, KJ; Gilbert, DL.
Preliminary evaluation of child self-rating using the Child Tourette Syndrome Impairment Scale.
Developmental Medicine and Child Neurology.
2017;
59:284-290.
Feist, TB; Campbell, JL; LaBare, JA; Gilbert, DL.
Challenges in Implementation of the New Accreditation System: Results From a National Survey of Child Neurology Program Coordinators.
Journal of Child Neurology.
2017;
32:397-402.
Wink, LK; Pedapati, EV; Horn, PS; McDougle, CJ; Erickson, CA.
Multiple Antipsychotic Medication Use in Autism Spectrum Disorder.
Journal of Child and Adolescent Psychopharmacology.
2017;
27:91-94.
Shaffer, RC; Pedapati, EV; Shic, F; Gaietto, K; Bowers, K; Wink, LK; Erickson, CA.
Brief Report: Diminished Gaze Preference for Dynamic Social Interaction Scenes in Youth with Autism Spectrum Disorders.
Journal of Autism and Developmental Disorders.
2017;
47:506-513.
Wink, LK; Minshawi, NF; Shaffer, RC; Plawecki, MH; Posey, DJ; Horn, PS; Adams, R; Pedapati, EV; Schaefer, TL; McDougle, CJ; et al.
D-Cycloserine enhances durability of social skills training in autism spectrum disorder.
Molecular Autism.
2017;
8.
Gilbert, DL; Horn, PS; Kang, PB; Mintz, M; Joshi, SM; Jr, RH; Bale, JF.
Child Neurology Recruitment and Training: Views of Residents and Child Neurologists From the 2015 AAP/CNS Workforce Survey.
Pediatric Neurology.
2017;
66:89-95.
Erickson, CA; Ray, B; Wink, LK; Bayon, BL; Pedapati, EV; Shaffer, R; Schaefer, TL; Lahiri, DK.
Initial analysis of peripheral lymphocytic extracellular signal related kinase activation in autism.
Journal of Psychiatric Research.
2017;
84:153-160.